Serina Therapeutics files 8-K on certificate elimination

Serina Therapeutics filed an 8-K describing a Delaware certificate of elimination that removes its Series A Convertible Preferred Stock designation. The company said no Series A Preferred Stock shares are outstanding because all issued shares were converted into common stock.